(Q43689745)

English

Epstein-Barr virus infections after allogeneic stem cell transplantation: a comparison between non-malignant and malignant hematological disorders

scientific article published in October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Epstein-Barr virus infections after allogeneic stem cell transplantation: a comparison between non-malignant and malignant hematological disorders (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Epstein–Barr virus

1 reference

based on heuristic

inferred from title

author name string

Md Serajul Islam

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Parameswaran Anoop

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Edward C Gordon-Smith

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Phil Rice

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Preeti Datta-Nemdharry

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Judith C W Marsh

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

344-350

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

EBV-related disease following haematopoietic stem cell transplantation with reduced intensity conditioning

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

Cytotoxic T lymphocyte responses to Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

Retrospective evaluation of serum Epstein Barr virus DNA levels in 406 allogeneic stem cell transplant patients

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment.

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

Guidelines for the diagnosis and management of aplastic anaemia

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

Chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

Comparison of quantitative competitive PCR with LightCycler-based PCR for measuring Epstein-Barr virus DNA load in clinical specimens

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

Active Epstein-Barr virus infection after allogeneic stem cell transplantation: re-infection or reactivation?

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT.

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

Implications of CD34+ cell dose on clinical and haematological outcome of allo-SCT for acquired aplastic anaemia.

1 reference

https://api.crossref.org/works/10.1179%2F102453310X12647083621047

21 January 2018

Identifiers

10.1179/102453310X12647083621047

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43689745&oldid=2102533330"